Clinical Trial Update: FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan [Phase 3]

View source ↗

Summary

Phase 3 trial FINEPKT evaluates finerenone for proteinuria in kidney transplant recipients; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: kewen Chen,MD | Conditions: Kidney Transplantation Recipients, Proteinuria Patients | Phase 3 | Status: ACTIVE_NOT_RECRUITING